spacer
home > pmps > winter 2017 > inhalation education
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Inhalation Education

There are several advantages when using inhaled therapeutics, and they offer promising future growth in the respiratory market. According to the NIH, a nominal dose is ‘the total prescribed dose’ of an inhalable therapeutic. Commonly observed actual amounts (medicament effectively reaching the lung), however, range between 6 and 60% of the nominal measurement. Such incomplete prescriptions pose safety risks to patients and reduce the effectiveness of their treatments. The successful use of respiratory delivery devices depends on a number of considerations, including:
  • Properties of the lung
  • Disease state
  • Breathing patterns
  • Delivery techniques


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Joining the company just a few years after its creation, Craig Baker is Vice President at Noble. He holds an undergraduate degree from the University of Iowa, US, and a Master’s degree from the University of South Carolina, US. In addition, Craig has 10 years of management experience in the marketing industry and the pharmaceutical and healthcare field. This unique insight into both industries is an important advantage for the future growth of Noble.
spacer
Craig Baker
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Distributor Oppurtunities

Have an appetite for success – Want to expand your product portfolio – Fancy being part of something special??
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 1st Quarter 2014

Synergy Research Group

In summary, Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement